Y070-0862 Screening compound: 2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-phenylacetamide

Y070-0862 Screening compound: 2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-phenylacetamide
Y070-0862 Screening compound: 2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y070-0862
2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y070-0862

Molecular Formula

C26H23N3O4 (C26 H23 N3 O4)

Compound Name

2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-phenylacetamide

IUPAC name

2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1234-tetrahydroquinoxalin-2-yl}-N-phenylacetamide

SMILES

COc1ccc(/C=C/C(N(C2CC(Nc3ccccc3)=O)c(cccc3)c3NC2=O)=O)cc1

InChI

InChI=1S/C26H23N3O4/c1-33-20-14-11-18(12-15-20)13-16-25(31)29-22-10-6-5-9-21(22)28-26(32)23(29)17-24(30)27-19-7-3-2-4-8-19/h2-16,23H,17H2,1H3,(H,27,30)(H,28,32)/t23-/m0/s1

InChI Key

ZGDFMXGOJJJXBJ-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD03212313

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.458

Distribution Coefficient, logD

3.456

Water Solubility, LogSw

-3.76

Polar Surface Area

69.526

Acid Dissociation Constant (pKa)

9.73

Base Dissociation Constant (pKb)

2.20

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

11.50

Y070-0862 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with Y070-0862 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y070-0862?
Check Price and Availability of Y070-0862, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y070-0862 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y070-0862
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y070-0862
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y070-0862 available by request